Opt-out HIV Testing as a Public Health Tool CME/CE

Author Information and Disclosures

Release Date: March 31, 2008Valid for credit through March 31, 2009

Credits Available
Physicians - maximum of 1.5 AMA PRA Category 1 Credit(s) for physicians;
Nurses - 1.5 nursing contact hours (None of these credits is in the area of pharmacology)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity

  1. Expanded HIV Testing in the Public Health Arena: Implementing the CDC RecommendationsDr. Bernard M. Branson discusses the rationale for the CDC guidelines for expanded HIV testing in the public health arena and outlines strategies for their implementation by public health officials.
  2. The Role of Public Health in HIV Opt-out Testing: An Expert Interview With Dr. Wayne A. DuffusDr. Wayne A. Duffus discusses the implementation of the CDC guidelines for HIV testing in public health clinics and stresses the role of PH professionals in this evolving effort.
  3. HIV Testing in Public Health Clinics: Applying New CDC GuidelinesDr. Wilbert Jordan takes the reader through a scenario of implementing expanded HIV testing and linkage to effective care in 4 county public health clinics.

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.


Gilead

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Describe CDC's new recommendations for HIV screening and the rationale behind them.
  2. Review current epidemiologic and impact information specific to HIV opt-out testing and increased recognition of HIV-positive individuals.
  3. Identify approaches to facilitating/implementing and evaluating the success of routine HIV testing conducted in the public health arena.
  4. List potential management issues in public health associated with implementing increased HIV testing.
Authors and Disclosures

Bernard M. Branson, MD
Disclosure: Bernard M. Branson, MD, has disclosed no relevant financial relationships.


Wayne A. Duffus, MD, PhD
Disclosure: Wayne A. Duffus, MD, PhD, has disclosed that he has received grants for clinical research from Abbott and that he has served on the speaker's bureau for Gilead.


Wilbert C. Jordan, MD, MPH
Disclosure: Wilbert C. Jordan, MD, MPH, has disclosed that he has received grants for clinical research from Gilead and Roche and has received grants for educational activities from Gilead and GlaxoSmithKline. Dr. Jordan has also disclosed that he has served as an advisor or consultant to Bristol-Myers Squibb, Gilead, GlaxoSmithKline, and Tibotec.


Peggy Keen, PhD, FNP
Disclosure: Peggy Keen, PhD, FNP, has disclosed no relevant financial relationships.


Thomas Maxwell Mundy, MD
Disclosure: Thomas Maxwell Mundy, MD, has disclosed no relevant financial relationships.


Sussan K. Sutphen, MD, MEd
Disclosure: Sussan K. Sutphen, MD, MEd, has disclosed no relevant financial relationships.


 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

 
This Activity is sponsored by Medscape Continuing Education Provider Unit.

Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.5 contact hour(s) of continuing nursing education for RNs and APNs; none of these credits is in the area of pharmacology.

Provider Number: 6FDKKC-PRV-05

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.